Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) Research & Development (2017 - 2025)

Historic Research & Development for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to $276000.0.

  • Catheter Precision's Research & Development rose 33809.52% to $276000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $625000.0, marking a year-over-year increase of 26764.71%. This contributed to the annual value of $272000.0 for FY2024, which is 4273.68% down from last year.
  • As of Q3 2025, Catheter Precision's Research & Development stood at $276000.0, which was up 33809.52% from $155000.0 recorded in Q2 2025.
  • In the past 5 years, Catheter Precision's Research & Development ranged from a high of $3.7 million in Q4 2021 and a low of -$11000.0 during Q4 2023
  • Its 5-year average for Research & Development is $1.0 million, with a median of $155000.0 in 2025.
  • Per our database at Business Quant, Catheter Precision's Research & Development tumbled by 10714.29% in 2023 and then skyrocketed by 92727.27% in 2024.
  • Catheter Precision's Research & Development (Quarter) stood at $3.7 million in 2021, then plummeted by 95.87% to $154000.0 in 2022, then plummeted by 107.14% to -$11000.0 in 2023, then surged by 927.27% to $91000.0 in 2024, then surged by 203.3% to $276000.0 in 2025.
  • Its Research & Development was $276000.0 in Q3 2025, compared to $155000.0 in Q2 2025 and $103000.0 in Q1 2025.